Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Failure, Acute 1Hepatitis B 1Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

entecavir 4Lamivudine 4Sorafenib 2polysaccharide MGN3 1navitoclax 1lens intermediate filament proteins 1human papillomavirus vaccine, L1 type 16, 18 1hepatitis B hyperimmune globulin 1adefovir dipivoxil 1Tumor Necrosis Factor-alpha 1Tetanus Toxoid 1Rapid Diagnostic Tests 1Raltegravir Potassium 1Radiofrequency Ablation 1Polymorphism, Genetic 1Pneumococcal Vaccines 1Pharmaceutical Preparations 1PHY 906 1Measles-Mumps-Rubella Vaccine 1Heptavalent Pneumococcal Conjugate Vaccine 1Hepatitis B Vaccines 1Enzyme-Linked Immunosorbent Assay 1Engerix-B 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hepatitis B × adefovir dipivoxil × Clear all
NCT00059267 2024-11-15

Prevention of Recurrent Hepatitis B After Liver Transplantation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed
317 enrolled
Gastrointestinal

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Failure, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡